Cojutti P.; Candoni A.; Forghieri F.; Isola M.; Zannier M.E.; Bigliardi S.; Luppi M.; Fanin R.; Pea F., Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2016, 118, pp. 474 - 479 [Scientific article]
Cojutti P.; Scarparo C.; Sartor A.; Coato P.; Rigoli R.; Pea F., A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy, «DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE», 2015, 81, pp. 53 - 56 [Scientific article]
Pea, Federico; Cojutti, Pier Giorgio, Drugs and blood cells, in: Hematologic Problems in the Critically Ill, Milan, Springer-Verlag Milan, 2015, pp. 111 - 147 [Legal Commentary]
Pea F.; Cojutti P.; Tursi V.; Livi U.; Baraldo M., Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia, «TRANSPLANT INFECTIOUS DISEASE», 2015, 17, pp. 926 - 928 [Comment or similar]
Cojutti P.; Crapis M.; Bassetti M.; Hope W.; Pea F., Linezolid underexposure in a patient co-treated with venlafaxine, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2015, 71, pp. 1285 - 1286 [Scientific article]
Cojutti P.; Maximova N.; Crichiutti G.; Isola M.; Pea F., Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: A step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2015, 70, Article number: dku337 , pp. 198 - 206 [Scientific article]
Pai M.P.; Cojutti P.; Pea F., Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections, «CLINICAL PHARMACOKINETICS», 2015, 54, pp. 933 - 941 [Scientific article]
Cojutti P.; Maximova N.; Pea F., Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2015, 59, pp. 5535 - 5541 [Scientific article]
Pea F.; Crapis M.; Cojutti P.; Bassetti M., Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia, «INFECTION», 2014, 42, pp. 207 - 210 [Scientific article]
Pea F.; Dose L.; Cojutti P.; Baraldo M.; Fontana F.; Favaretti C.; Furlanut M., Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoring, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2014, 115, pp. 432 - 437 [Scientific article]
Pea F.; Righi E.; Cojutti P.; Carnelutti A.; Baccarani U.; Soardo G.; Bassetti M., Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2014, 69, pp. 2585 - 2586 [Comment or similar]
Pai M.P.; Cojutti P.; Pea F., Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m2) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring, «CLINICAL PHARMACOKINETICS», 2014, 53, pp. 753 - 762 [Scientific article]
Pea F.; Cadeo B.; Cojutti P.G.; Pecori D.; Bassetti M., Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report, «THERAPEUTIC DRUG MONITORING», 2014, 36, pp. 687 - 689 [Scientific article]
Cattani G, Arnoldo L, Tricarico P, Agnoletto A, Tosolini F, Cristiani M, Canciani L, Gangi F, Tonutti G, Pletti L, Prati M, Cojutti P, Pea F, Brusaferro S, Chittaro M, Barazzutti C, Monteverdi D, Lavia B, Polypharmacy in an Italian Regional Health system: a survey on drugs use in different healthcare settings: Giovanni Cattani, «EUROPEAN JOURNAL OF PUBLIC HEALTH», 2014, 24, pp. 1 - 2 [Scientific article]
Bassetti M.; Villa G.; Ansaldi F.; De Florentiis D.; Tascini C.; Cojutti P.; Righi E.; Sartor A.; Crapis M.; De Rosa F.G.; Pea F.; Menichetti F., Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients, «INTENSIVE CARE MEDICINE», 2014, 41, pp. 366 - 368 [Scientific article]
